The willingness to pay for vaccination against tick-borne encephalitis and implications for public health policy: Evidence from Sweden

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Slunge, Daniel ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DRUG COST; EDUCATIONAL STATUS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; INCIDENCE; INCOME; INFECTION RISK; KNOWLEDGE; MALE; PATIENT ATTITUDE; PERCEPTION; RISK FACTOR; SWEDEN; TICK BITE; TICK BORNE ENCEPHALITIS; TRUST; URBAN AREA; VACCINATION; ADOLESCENT; ATTITUDE TO HEALTH; ECONOMICS; ENCEPHALITIS, TICK-BORNE; HEALTH CARE COST; HEALTH SURVEY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

VIRUS VACCINE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ENCEPHALITIS, TICK-BORNE; FEMALE; HEALTH EXPENDITURES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SWEDEN; VACCINATION; VIRAL VACCINES; YOUNG ADULT;

EID: 84955457198     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143875     Document Type: Article

References (32)

1. Haglund M, Forsgren M, Lindh G, Lindquist L. A 10-year follow-up study of tick-borne encephalitis in the stockholm area and a review of the literature: Need for a vaccination strategy. Scandinavian Journal of Infectious Diseases. 1996; 28: 217-24. doi: 10.3109/00365549609027160
2. Finnish Institute of Public Health. Pitäisikö tbe-rokotusohjelmaalaajentaa? Puutiaisaivokuumerokotustyöryhmän raportti-should the tbe immunisation program be expanded? Report of the tick-borne encephalitis immunisation working group; 2013;44: p. 1-49.
3. Smit R. Cost-effectiveness of tick-borne encephalitis vaccination in slovenian adults. Vaccine. 2012; 30: 6301-6. doi: 10.1016/j.vaccine.2012.07.083
4. Askling HH, Insulander M, Hergens M-P, Leval A. Tick borne encephalitis (tbe)-vaccination coverage and analysis of variables associated with vaccination, sweden. Vaccine. 2015; 33: 4962-8. doi: 10. 1016/j.vaccine.2015.07.030
5. Haglund M, Gönther G. Tick-borne encephalitis-pathogenesis, clinical course and long-Term followup. Vaccine. 2003; 21: S11-S8. doi: 10.1016/s0264-410x(02)00811-3
6. Engman ML, Lindstrom K, Sallamba M, Hertz C, Sundberg B, Hansson ME, et al. One-year follow-up of tick-borne central nervous system infections in childhood. Pediatr Infect Dis J. 2012; 31: 570-4. Epub 2012/02/16. doi: 10.1097/INF.0b013e31824f23c0
7. European Centre for Disease Prevention and Control. Epidemiological situation of tick-borne encephalitis in the european union and european free trade association countries. 2012. doi: 10.2900/62311
8. European Centre for Disease Prevention and Control. Annual epidemiological report 2014-emerging and vector-borne diseases. Stockholm: 2014.
9. WHO. Vaccines against tick-borne encephalitis: Who position paper-recommendations. Vaccine. 2011; 29: 8769-70. doi: http://dx.doi.org/10.1016/j.vaccine.2011.07.024
10. Heinz FX, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine. 2007; 25: 7559-67. Epub 2007/09/18. doi: 10.1016/j.vaccine.2007.08.024
11. Heinz FX, Stiasny K, Holzmann H, Grgic-Vitek M, Kriz B, Essl A, et al. Vaccination and tick-borne encephalitis, central europe. Emerg Infect Dis. 2013; 19: 69-76. doi: 10.3201/eid1901.120458
12. Kunz C. Tbe vaccination and the austrian experience. Vaccine. 2003; 21: 50-5. doi: 10.1016/s0264-410x(02)00813-7
13. Kosnik IG, Lah AK. A campaign to increase the vaccination rate in a highly endemic tick-borne encephalitis region of slovenia. Vaccine. 2013; 31: 732-4. doi: 10.1016/j.vaccine.2012.12.005
14. Rapola S. National immunization program in finland. 2007. 2007;66. Epub 2012-03-18. doi: 10.3402/ijch.v66i5.18310
15. Zavadska D, Anca I, Andre F, Bakir M, Chlibek R, Cižman M, et al. Recommendations for tick-borne encephalitis vaccination from the central european vaccination awareness group (cevag). Human Vaccines and Immunotherapeutics. 2014; 9: 362-74. doi: 10.4161/hv.22766
16. Palanca-Tan R. The demand for a dengue vaccine: A contingent valuation survey in metro manila. Vaccine. 2008; 26: 914-23. doi: 10.1016/j.vaccine.2007.12.011
17. Suraratdecha C, Ainsworth M, Tangcharoensathien V, Whittington D. The private demand for an aids vaccine in thailand. Health Policy. 2005; 71: 271-87. doi: 10.1016/j.healthpol.2004.05.005
18. Cropper ML, Haile M, Lampietti J, Poulos C, Whittington D. The demand for a malaria vaccine: Evidence from ethiopia. Journal of Development Economics. 2004; 75: 303-18. doi: 10.1016/j.jdeveco. 2003.02.006
19. Streefland P, Chowdhury AMR, Ramos-Jimenez P. Patterns of vaccination acceptance. Social Science and Medicine. 1999; 49: 1705-16. doi: 10.1016/S0277-9536(99)00239-7
20. Whittington D, Sur D, Cook J, Chatterjee S, Maskery B, Lahiri M, et al. Rethinking cholera and typhoid vaccination policies for the poor: Private demand in kolkata, india. World Development. 2009; 37: 399-409. doi: 10.1016/j.worlddev.2008.04.002
21. Desjeux G, Galoisy-Guibal L, Colin C. Cost-benefit analysis of vaccination against tick-borne encephalitis among french troops. PharmacoEconomics. 2005; 23: 913-26. doi: 10.2165/00019053-200523090-00004
22. Schwarz B. Gesundheitsokonomische aspekte der fruhsommermeningoenzephalitis in osterreich. Auswirkungen der impfkampagne 1981 bis 1990. Wiener Medizinische Wochenschrift. 1993; 143: 551-5.
23. Carson RT. Contingent valuation: A practical alternative when prices aren't available. The Journal of Economic Perspectives. 2012; 26: 27-42. doi: 10.1257/jep.26.4.27
24. Freeman AM III, Herriges JA, Kling CL. The measurement of environmental and resource values: Theory and methods. 3 ed. New York: RFF Press; 2014.
25. List JA, Gallet CA. What experimental protocol influence disparities between actual and hypothetical stated values? Environmental and Resource Economics. 2001; 20: 241-54. doi: 10.1023/A:1012791822804
26. Cummings RG, Taylor LO. Unbiased value estimates for environmental goods: A cheap talk design for the contingent valuation method. The American Economic Review. 1999; 89: 649-65. doi: 10.1257/aer. 89.3.649
27. Morrison M, Brown TC. Testing the effectiveness of certainty scales, cheap talk, and dissonance-minimization in reducing hypothetical bias in contingent valuation studies. Environmental and Resource Economics. 2009; 44: 307-26. doi: 10.1007/s10640-009-9287-3
28. Blomquist GC, Blumenschein K, Johannesson M. Eliciting willingness to pay without bias using followup certainty statements: Comparisons between probably/definitely and a 10-point certainty scale. Environmental & Resource Economics. 2009; 43: 473-502. doi: 10.1007/s10640-008-9242-8
29. Grossman M. On the concept of health capital and the demand for health. Journal of Political Economy. 1972; 80: 223-55. doi: 10.1086/259880
30. Hanemann WM. Welfare evaluations in contingent valuation experiments with discrete responses. American Journal of Agricultural Economics. 1984; 66: 332-41.
31. Haab TC, McConnell KE. Valuing environmental and natural resources: The econometrics of non-market valuation. Cheltenham: Edward Elgar; 2002.
32. Jaenson TG, Jaenson DG, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick ixodes ricinus during the past 30 years in sweden. Parasit Vectors. 2012; 5: 8. doi: 10.1186/1756-3305-5-8